I agree that this site is using cookies. You can find further informations here.
X
Mirza, Mansoor R.
823  results:
Search for persons X
?
1

Progression-free survival and safety at 3.5 years of follow..:

González-Martín, Antonio ; Pothuri, Bhavana ; Vergote, Ignace...
Future Oncology.  , 2024
Link: https://doi.org/10.2217/..
 
?
2

A plain language summary of publication of the efficacy and..:

Mirza, Mansoor R ; González-Martín, Antonio ; Graybill, Whitney S...
Future Oncology.  20 (2024)  13 - p. 799-809 , 2024
Link: https://doi.org/10.2217/..
 
?
3

Patterns of initial ovarian cancer recurrence on niraparib ..:

Kamrava, Mitchell R. ; Gonzalez-Martin, Antonio ; Pothuri, Bhavana...
Gynecologic Oncology.  189 (2024)  - p. 68-74 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Survival and modelled cancer antigen-125 ELIMination rate c..:

Corbaux, Pauline ; You, Benoit ; Glasspool, Rosalind M....
European Journal of Cancer.  191 (2023)  - p. 112966 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Safety, Efficacy, and Biomarker Analyses of Dostarlimab in ..:

Oaknin, Ana ; Pothuri, Bhavana ; Gilbert, Lucy...
Clinical Cancer Research.  29 (2023)  22 - p. 4564-4574 , 2023
Link: https://doi.org/10.1158/..
 
?
6

Progression-free survival and safety at 3.5 years of follow..:

González-Martín, Antonio ; Pothuri, Bhavana ; Vergote, Ignace...
European Journal of Cancer.  189 (2023)  - p. 112908 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Optimizing disease progression assessment using blinded cen..:

Herzog, Thomas J ; Wahab, Shaun A ; Mirza, Mansoor R...
International Journal of Gynecologic Cancer.  33 (2023)  11 - p. 1733-1742 , 2023
Link: https://doi.org/10.1136/..
 
?
8

Safety and management of niraparib monotherapy in ovarian c..:

Monk, Bradley J ; González-Martin, Antonio ; Buckley, Lynn...
International Journal of Gynecologic Cancer.  33 (2023)  6 - p. 971-981 , 2023
Link: https://doi.org/10.1136/..
 
?
9

Prospective evaluation of the tolerability and efficacy of ..:

Mirza, Mansoor R. ; González‐Martín, Antonio ; Graybill, Whitney S....
Cancer.  129 (2023)  12 - p. 1846-1855 , 2023
Link: https://doi.org/10.1002/..
 
?
10

Maintenance olaparib plus bevacizumab in patients with newl..:

González-Martín, Antonio ; Desauw, Christophe ; Heitz, Florian...
European Journal of Cancer.  174 (2022)  - p. 221-231 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Niraparib treatment for patients withBRCA-mutated ovarian c..:

González-Martín, Antonio ; Matulonis, Ursula A ; Korach, Jacob...
Future Oncology.  18 (2022)  23 - p. 2505-2536 , 2022
Link: https://doi.org/10.2217/..
 
?
12

Molecular and clinical predictors of improvement in progres..:

Lee, Chee Khoon ; Friedlander, Michael L. ; Tjokrowidjaja, Angelina...
Cancer.  127 (2021)  14 - p. 2432-2441 , 2021
Link: https://doi.org/10.1002/..
 
?
13

Management of Endometrial Cancer:

Mirza, Mansoor R - 1st ed. 2020 . , 2020
Link: https://doi.org/10.1007/..
 
?
14

Long-term safety in patients with recurrent ovarian cancer ..:

Mirza, Mansoor R. ; Benigno, B. ; Dørum, A....
Gynecologic Oncology.  159 (2020)  2 - p. 442-448 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Efficacy and safety of niraparib as maintenance treatment i..:

Fabbro, Michel ; Moore, Kathleen N. ; Dørum, Anne...
Gynecologic Oncology.  152 (2019)  3 - p. 560-567 , 2019
Link: https://doi.org/10.1016/..
 
1-15